Anthrax Sent in Error to 86 Labs

A US Army lab shipped live spores of the deadly bacterium because of improper irradiation protocols, a Department of Defense review has found.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, YUVAL MADARAn incident in May of this year, in which a private company inadvertently received live anthrax spores from a US Army lab, has led to the revelation that such shipments have been sent dozens of times over the last decade. According to the latest numbers from the Department of Defense (DoD), 86 laboratories had live anthrax—instead of inactivated cells—sent to them directly by the Army facility.

“A key finding by the [DoD] committee is that there is insufficient technical information in the broader scientific community to guide the development of thoroughly effective protocols for inactivation of spores and viability testing of BA [Bacillus anthracis],” according to the DoD report, published July 13. “This has contributed to the creation of protocols that do not completely or permanently sterilize BA with gamma irradiation.”

The DoD committee found that staff members at the Army lab followed the correct protocols, but that the protocols had deficiencies that could lead to insufficient inactivation of the bacteria.

“By any measure, this was a massive institutional failure,” Deputy Secretary of Defense Bob Work told reporters last week (July 23), according to USA Today. The news outlet also reported ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies